Danaher Corporation (LON:0R2B)
London · Delayed Price · Currency is GBP · Price in USD 218.94
-0.36 (-0.16%)
At close: Jan 30, 2026
Danaher Market Cap
Danaher has a market cap or net worth of 112.79 billion as of January 30, 2026. Its market cap has decreased by -19.70% in one year.
Market Cap
112.79B
Enterprise Value
122.85B
Revenue
18.25B
Ranking
n/a
PE Ratio
42.00
Stock Price
218.94
Market Cap Chart
Since December 10, 1969, Danaher's market cap has increased from 207.76M to 112.79B, an increase of 54,186.59%. That is a compound annual growth rate of 11.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 112.79B | -6.12% |
| Dec 31, 2025 | 120.14B | -9.28% |
| Dec 31, 2024 | 132.43B | -1.32% |
| Dec 29, 2023 | 134.20B | -16.31% |
| Dec 30, 2022 | 160.36B | -7.64% |
| Dec 31, 2021 | 173.63B | 50.22% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 210.92B |
| GSK plc | 75.29B |
| Haleon | 33.75B |
| Smith & Nephew | 10.55B |
| Convatec Group | 4.48B |
| Hikma Pharmaceuticals | 3.39B |
| Genus | 2.11B |
| HUTCHMED (China) | 1.89B |